Clinical Trials · NCT07282769
Semaglutide (Wegovy) Treatment for Trichotillomania
- Phase
- Phase 2
- Recruitment status
- Not Yet Recruiting
- Sponsor
- University of Chicago
- Enrollment
- 10
- Start date
- Jun 2026
- Locations
- See registry
- Primary endpoint
- NIMH Trichotillomania Severity Scale